Phased III trails has finished,approved on the market by CFDA;
High efficiency; Large Capability with two factories in China.
Realize a complete sample pretreatment and nucleic acid extraction workflow through high throughput, high precision, and high efficiency.
The kit combines rapid RNA release technology with high-efficiency PCR amplification assays, and can detect 2019-nCov through changes in fluorescence signals on a fluorescent quantitative PCR instrument.
SINOVAC CoronaVac is a vaccine based on inactivated whole virion technology. Trials have commenced in Brazil and Indonesia etc.